Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
|Articles|December 23, 2022
News Roundup: December 19 to December 23
Author(s)Lauren Biscaldi, MS
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
FDA Approves First-In-Class Twice-Yearly Treatment for HIV
Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.
CBD May Help Mitigate Opioid Withdrawal Symptoms
In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.
Examining Rates of COVID-19 Rebound With Antiviral Therapies
Research tells a different story than recent news headlines.
Copay Caps for Insulin Lower Total Spending for Medicare Beneficiaries
The Medicare Part D Senior Savings Model—a CMS effort to test $35 copays for insulin—led to lowered total costs for beneficiaries.
How General Vaccine Hesitancy Is Impacting Teen COVID-19 Vaccination Rates
The COVID-19 vaccine rate for teenagers lags behind vaccination rates for adults. Does parental hesitancy for vaccines in general play a role?
Advertisement
Related to this article
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026
3
FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026
4
Pharmacists Step Up on Test-To-Treat This American Pharmacist Month
5